The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure

With the development of regenerative medicine, a variety of mesenchymal stem cells (MSCs) are increasingly considered for the treatment of premature ovarian failure (POF). Reportedly, bone marrow-derived MSCs ...

Source: Stem Cell Research and Therapy - October 4, 2018 Category: Stem Cells Authors: Yantao He, Dongmei Chen, Lingling Yang, Qiaoni Hou, Huiming Ma and Xian Xu Tags: Review Source Type: research